FindTrial
Sign In

The clinical study on scanning for HDV patients by high throughput antibody capture assay on nanostructureed plasmonic gold substrate

The clinical study on scanning for HDV patients by high throughput antibody capture assay on nanostructureed plasmonic gold substrate

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17012463
Enrollment
Unknown
Registered
2017-08-24
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

viral hepatitis

Interventions

Gold Standard:ELISA
Index test:high&#32
throughput&#32
antibody&#32
capture&#32
assay&#32
on&#32
nanostructureed&#32
plasmonic&#32
gold&#32
substrate

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: HBsAg positive patient

Exclusion criteria

Exclusion criteria: The use of immunosuppressive agents and immunocompromised patients

Design outcomes

Primary

MeasureTime frame
HDV IgG antibody;—

Countries

China

Contacts

Public ContactChen Xiaohua

Department of infectious disease, Shanghai Sixth People's Hospital

chenxiaohua2000@163.com+86 18930172758

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026